Preclinical Characterization of NVR 3-778, a First-in-Class Capsid Assembly Modulator against Hepatitis B Virus

Lam, AM; Espiritu, C; Vogel, R; Ren, SP; Lau, V; Kelly, M; Kuduk, SD; Hartman, GD; Flores, OA; Klumpp, K

Lam, AM (reprint author), Novira Therapeut Inc, Spring House, PA 19477 USA.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2019; 63 (1):

Abstract

NVR 3-778 is the first capsid assembly modulator (CAM) that has demonstrated antiviral activity in hepatitis B virus (HBV)-infected patients. NVR 3-77......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索